Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Prieto, Luis M ^a   González Tomé, María Isabel ^b   Muñoz, Eloy ^b   Fernández Ibieta, María ^a   Soto, Beatriz ^a   Álvarez, Ana ^a   Navarro, Maria Luisa ^c   Roa, Miguel ángel ^d   Beceiro, José ^e   de José, María Isabel ^f   Olabarrieta, Iciar ^g   Lora, David ^b   Ramos, José Tomás ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL DE MÓSTOLES   (Spain)

^e HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Antiretrovirals; Birth defects; HIV

Indexed keywords

ABACAVIR; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BIRTH DEFECT; CARDIOVASCULAR MALFORMATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIGESTIVE SYSTEM MALFORMATION; DISEASE ASSOCIATION; FEMALE; FETUS RISK; FIRST TRIMESTER PREGNANCY; GENITAL MALFORMATION; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRONEPHROSIS; INFANT; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; MONOTHERAPY; MUSCULOSKELETAL SYSTEM MALFORMATION; OBSERVATIONAL STUDY; PREMATURITY; PRENATAL DRUG EXPOSURE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SPAIN; THIRD TRIMESTER PREGNANCY; URINARY TRACT MALFORMATION; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL ABNORMALITIES; HIV INFECTIONS; MULTICENTER STUDY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PROSPECTIVE STUDY; TRANSMISSION; VERTICAL TRANSMISSION;

ANTI-RETROVIRAL AGENTS; COHORT STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 84923910513     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0700-3     Document Type: Article

References (35)

1. European Collaborative Study: Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005, 40:458-465.
2. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med 1994, 331:1173-1180.
3. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed 20 August 2014.
4. Grupo de expertos de la Secretaría del Plan Nacional sobre el Sida (SPNS), Grupo de Estudio de Sida (GeSIDA)/Sociedad Española de Ginecología y Obstetricia (SEGO) y Sociedad Española de Infectología Pediátrica (SEIP) Documento de Consenso para el seguimiento de la infección por el VIH en relación con la reproducción, embarazo, parto y profilaxis de la transmisión vertical del niño expuesto. January 2013. Available at: http://www.msssi.gob.es/. Accessed 23 September 2014.
5. Prieto LM, González-Tomé MI, Muñoz E, Fernández-Ibieta M, Soto B, Del Rosal T, Cuadrado I, Navarro ML, Roa MA, Beceiro J, de José MI, Santos MJ, Lora D: Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs: Low rates of mother-to-child transmisión of HIV-1 and risk factors for infection in Spain: 2000-2007. Pediatr Infect Dis J 2012, 31:1053-1058.
6. Antiretroviral Prgenancy Steering Committee. Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 July 2008. Wilmington, NC: Registry Coordinating Center; 2008. Available at: www.APRegistry.com. Accessed 20 August 2013.
7. European Collaborative Study: Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr 2005, 40:116-118.
8. Brogly SB, Abzug MJ, Watts DH, Cunningham CK, Williams PL, Oleske J, Conway D, Sperling RS, Spiegel H, Van Dyke RB: Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J 2010, 29:721-727.
9. Knapp KM, Brogly SB, Muenz DG, Spiegel HM, Conway DH, Scott GB, Talbot JT, Shapiro DE, Read JS: Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J 2012, 31:164-170.
10. Capparelli E, Rakhmania N, Mirochnick M: Pharmacotherapy of perinatal HIV. Sem Fetal Neonat Med 2005, 10:161-175.
11. Siu SS, Hok-Keung J, Pang MW, Chiu PY, Lau TK: Placental transfer of zidovudine in first trimester of pregnancy. Obstet Gynecol 2005, 106:824-827.
12. Thorne C, Newell ML: Safety of agents used to prevent mother- to-child transmission of HIV. Drug Saf 2007, 30:203-213.
13. Watts DH, Li D, Handelsman E, Tilson H, Paul M, Foca M, Vajaranant M, Diaz C, Tuomala R, Thompson B: Assesment of birth defects according to maternal therapy among infants in the women and infants transmission study. J Acquir Immune Defic Syndr 2007, 44:299-305.
14. Sibiude J, Mandelbrot L, Blanche S, Le Chenadec J, Boullag-Bonnet N, Faye A, Dollfus C, Tubiana R, Bonnet D, Lelong N, Khoshnood B, Warszawski J: Association between Prenatal Exposure to Antiretroviral Therapy and Birth Defects: An Analysis of the French Perinatal Cohort Study (ANRS CO1/CO11). PLoS Med 11(4): e1001635. doi:10.1371/journal.pmed.1001635
15. Taylor GP, Low-Beer N: Antiretroviral therapy in pregnancy-focus on safety. Pract Drug Saf 2001, 24:683-702.
16. De Santis M, Carducci B, de Santis L, Cavaliere AF, Straface G: Periconcepcional exposure to efavirenz and neural tube defects. Arch Intern Med 2002, 162:190.
17. Saitoh A, Hull AD, Franklin P, Spector SA: Myelomeningocele in an infant with intrauterine exposure to efavirenz. J Perinatol 2005, 25:555-556.
18. Ford N, Calmy A, Mofenson L: Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 2011, 25:2301-2304.
19. WHO. Use of efavirenz during pregnancy: A public health perspective. 2012. Disponible en http://www.who.int/hiv/pub/treatment2/efavirenz Accessed 20 August 2013.
20. EUROCAT (2012) EUROCAT Special Report: Congenital anomalies are a major group of mainly rare diseases. EUROCAT Central Registry, University of Ulster. Available at: http://www.eurocat-network.eu/content/Special-Report-Major-Group-of-Mainly-Rare-Diseases.pdf Accessed 20 August 2014
21. EUROCAT. EUROCAT Statistical Monitoring Report -2006. 2009. Available at: http://www.eurocat.ulster.ac.uk. Accessed 20 August 2014
22. Scheuerle A, Tilson H: Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Saf 2002, 11:465-475.
23. EUROCAT (2005) EUROCAT Guide 1.3 and reference documents. Instructions for the Registration and Surveillance of Congenital Anomalies. Available at: http://www.eurocat-network.eu/aboutus/datacollection/guidelinesforregistration/guide1_3instructionmanual Accessed 20 August 2014
24. Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L, ANRS French Perinatal Cohort: Mother-to-child transmission despite anti-retroviral therapy in the ANRS French perinatal cohort. AIDS 2008, 22:289-299.
25. Goetghebuer T, Haelterman E, Marvillet I, Barlow P, Hainaut M, Salameh A, Ciardelli R, Gerard M, Levy J: Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis. Eur J Pediatr 2009, 168:79-85.
26. von Linstow ML, Rosenfeldt V, Lebech AM, Storgaard M, Hornstrup T, Katzenstein TL, Pedersen G, Herlin T, Valerius NH, Weis N: Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008. HIV Med 2010, 11:448-456.
27. Townsend CL, Willey BA, Cortina-Borja M, Peckham CS, Tookey PA: Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007. AIDS 2009, 23:519-524.
28. Patel D, Thorne C, Fiore S, Newell ML, the European Collaborative Study: Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr 2005, 40:116-118.
29. Joao EC, Calvet GA, Krauss MR, Freimanis Hance L, Ortiz J, Ivalo SA, Pierre R, Reyes M, Heather Watts D, Read JS, NISDI Perinatal Study Group: Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. J Acquir Immune Defic 2010, 53:176-185.
30. Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K: Malformations in newborn: Results based on 30940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet 2002, 266:163-167.
31. Lai WW, Lipshultz SE, Easley KA, Starc TJ, Drant SE, Bricker JT, Colan SD, Moodie DS, Sopko G, Kaplan S: Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. J Am Coll Cardiol 1998, 32:1749-1755.
32. Hoffman JI, Kaplan S: The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
33. Martinez-Frias ML, Bermejo E: Frecuencia basal de defectos congénitos en España y su evolucion en el tiempo: utilidad y significado de las distintas cifras de frecuencia. Med Clin(Barc) 1999, 113:459-462. 35.
34. Salvador Peral J, García-Miñaur Rica S, Caballín Fernández MR, Mosquera Tenreiro C, Baena Díez N, García López E, Castro Laiz V, Guitart Feluibadaló M, Gabau Vila E, Plasència Taradach A: Registros poblacionales de defectos congénitos en España. An Pediatr (Barc) 1999, 48:575-582.
35. Laas E, Lelong N, Thieulin AC, Houyel L, Bonnet D, Ancel PY, Kayem G, Goffinet F, Khoshnood B, EPICARD Study Group: Preterm birth and congenital heart defects: a population-based study. Pediatrics 2012, 130:e829-e837.